Ross Acquisition Corp II (NYSE:ROSS) announced this afternoon that it has mutually terminated its combination with drug developer APRINOIA, effective immediately.
The parties did not disclose why they decided to nix the deal and did not provide further details.
Ross II inked its $319 million business combination with APRINOIA in January, originally bringing about $350.6 million into the deal from its trust. It supplemented this with $12.5 million in convertible notes, $7.5 million of which were to be funded by an affiliate of the SPAC’s CEO, President and Chairman Wilbur Ross, and APRINOIA was expected to receive a $10 million strategic investment from a pharmaceutical partner.
However, the SPAC saw 81.5% of its trust redeemed during previous extension meetings, leaving it with $65.3 million post-vote. It remains unclear whether Ross II will continue to search for an alternative target to combine with or liquidate, but it currently faces a deadline just weeks away on September 16.
Cambridge, Massachusetts-based APRINOIA is developing treatments and diagnostic tools for Alzheimer’s and Parkinson’s that target the toxic proteins that accelerate the diseases’ progression.
Shepherd Ave Capital Acquisition Corporation (NASDAQ:SPHAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SPHAU”, Thursday, December 5, 2024. The new SPAC intends to conduct a broad search for a combination target without a preference for a specific industry or region....
At the SPAC of Dawn SPACInsider has kept a close eye on how the new tariffs ushered in by a second Trump presidency could affect SPACs and their deals moving forward. But, there is a genre of SPAC deal that has cropped up in recent years essentially as a hedge to trade tensions and they...
Tavia Acquisition Corp. (NASDAQ:TAVIU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TAVIU”, Wednesday, December 4, 2024. The Company is strategically focused on sectors pivotal to advancing sustainability and innovation, including energy transition and critical materials, circular economy initiatives, and innovative...
Target Global I (NASDAQ:TGAA) has entered into a definitive agreement to combine with robotics firm VenHub at an enterprise value of $715 million. Pasadena, California-based VenHub is developing autonomous smart stores that serve customers products through app-based orders and a robotic serving and sorting arm. The combined company is expected to trade on the Nasdaq...
At the SPAC of Dawn Travel and hospitality were hot sectors for SPACs as they boomed during the pandemic because there was a obvious upside story to tell about where each target might be once the world reopened. Since then, SPACs have largely shied away from the industry. Part of this has been the less...